Aclaris Therapeutics, Inc.

NasdaqGS:ACRS Stock Report

Market Cap: US$149.1m

Aclaris Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ACRS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Aug 24BuyUS$472,757BML Capital Management, LLCCompany373,569US$1.29
31 Jul 24BuyUS$359,010BML Capital Management, LLCCompany273,730US$1.33
22 Jul 24BuyUS$201,808BML Capital Management, LLCCompany154,722US$1.33
05 Jul 24BuyUS$405,894BML Capital Management, LLCCompany352,397US$1.16
01 Jul 24BuyUS$1,742,075BML Capital Management, LLCCompany1,543,434US$1.15
18 Jun 24BuyUS$628,206BML Capital Management, LLCCompany545,000US$1.17
13 Jun 24BuyUS$1,781,897BML Capital Management, LLCCompany1,611,200US$1.15
04 Mar 24BuyUS$17,955Andrew Kenneth PowellIndividual14,500US$1.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACRS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,892,8132.65%
Hedge Funds14,250,00020%
General Public14,301,16920%
Institutions40,900,57557.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 70.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20%
BML Capital Management, LLC
14,250,000US$29.8m9.72%16.07%
6.57%
The Vanguard Group, Inc.
4,687,551US$9.8m-4.91%no data
4.65%
D. E. Shaw & Co., L.P.
3,320,206US$6.9m1.13%0.01%
4.21%
Millennium Management LLC
3,005,598US$6.3m-9.93%no data
3.86%
Rock Springs Capital Management LP
2,753,495US$5.8m0%0.17%
2.85%
BlackRock, Inc.
2,032,155US$4.2m-60.9%no data
2.7%
Stonepine Capital Management LLC
1,927,446US$4.0m0%1.5%
2.68%
Acadian Asset Management LLC
1,913,449US$4.0m-10.4%0.01%
2.68%
Trium Capital Managers Ltd
1,912,990US$4.0m1.11%2.18%
2.01%
Two Sigma Advisers, LP
1,436,900US$3.0m-0.98%0.01%
1.92%
Neal Walker
1,369,642US$2.9m5.43%no data
1.56%
Two Sigma Investments, LP
1,113,072US$2.3m-16.3%0.01%
1.4%
Bain Capital Life Sciences Investors, LLC
1,000,000US$2.1m-66.7%0.21%
1.35%
PEH Wertpapier AG
963,544US$2.0m0%0.13%
1.32%
Qube Research & Technologies Ltd
940,752US$2.0m-22.4%no data
1.29%
Deutsche Asset & Wealth Management
923,313US$1.9m-3.52%no data
1.29%
Renaissance Technologies LLC
922,200US$1.9m-44.9%no data
1.23%
Citadel Advisors LLC
875,216US$1.8m-5.89%no data
1.2%
Aldebaran Capital, LLC
858,152US$1.8m0%1.68%
1.09%
Geode Capital Management, LLC
774,137US$1.6m-50.5%no data
1.06%
Goldman Sachs Group, Investment Banking and Securities Investments
758,793US$1.6m631%no data
0.98%
Samsara BioCapital LLC
696,171US$1.5m0%0.19%
0.97%
FMR LLC
689,353US$1.4m2.61%no data
0.8%
Palo Alto Investors LP
569,832US$1.2m0%0.15%
0.73%
Northern Trust Global Investments
520,469US$1.1m-7.43%no data